MASLD 薬剤療法: 現在の基準,新興治療法,インドの医師のための実践的ガイド
1Professor, Department of Gastroenterology, Institute of Liver, Gastroenterology, and Pancreatico-Biliary Sciences, Sir Ganga Ram Hospital, Delhi, India, Corresponding Author, Orcid: https://orcid.org/0000-0001-6680-7227.
The Journal of the Association of Physicians of India
|August 21, 2025
まとめ
メタボリック機能障害に関連した脂肪性肝疾患 (MASLD) の管理は,肝臓の脂肪と炎症を標的とした新薬によって進化しています. このレビューは,MASLDの現行および新興の薬理学的な選択肢に関するインドの医師のための実践的なガイドラインを提供します.
科学分野:
- 肝病と代謝疾患について
- 薬理学と薬の開発
- 公衆衛生と疫学
背景:
- メタボリック機能障害に関連した脂肪性肝疾患 (MASLD),以前はNAFLDと呼ばれ,肥満と2型糖尿病 (T2DM) の増加により,特にインドでは,世界的な健康上の懸念が高まっています.
- MASLDは,単純な肉脂肪症から,繊維症のMASHまで,肝硬変,肝がん,心血管疾患のリスクを高めます.
- ライフスタイルの変化が優先されますが,薬理学的介入は進行性MASLDまたは高リスク患者にとって不可欠です.
研究 の 目的:
- MASLDの現行および新興の薬理学的治療法を包括的に検討する.
- インドの医師がMASLDを 管理する際の 実践的な根拠に基づいた勧告を提供すること.
- インドの状況に合わせた非性MASLD (F0-F3繊維症) の構造化された治療アルゴリズムを提示する.
主な方法:
- MASLDの薬理学的薬剤に関する最近の臨床試験データをレビューする.
- 重要なMASLD経路 (ステアトーシス,インスリン抵抗性,炎症,線維症) を標的とした新興治療法の分析.
- インドの薬の利用可能性,糖尿病の状況,および繊維症の重症度に基づく治療アルゴリズムの開発.
主要な成果:
- レスメチローム,GLP- 1RAs (セマグルチド),PPARアゴニスト (ピオグリタゾン,サログリタザー),SGLT2阻害剤,ビタミンEを含むいくつかの薬剤が有望である.
- ティルゼパチドやFGF類の新薬は将来の治療に大きく影響する可能性があります.
- 費用対効果を考慮して,インドでMASLDの管理のための実用的なアルゴリズムが提案されています.
結論:
- 薬学的治療は,特定の病原性メカニズムを標的とした進行性MASLDの管理にますます重要になっています.
- 効果,手頃な価格,実現可能性のバランスをとる 対応型の治療戦略は インドの多様な人口にとって不可欠です
- このレビューは,医師に日常的な臨床実践でMASLDケアを最適化するためのツールを備えています.
関連する概念動画
Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97
Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189
Drug Abuse and Addiction: Pharmacological Phenomena
655
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
655
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
MALDI-TOF Mass Spectrometry
5.2K
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
5.2K


